Olink investor relations material

Olink Holding AB, founded in Sweden but US listed, provides proteomics and genomics solutions to understand biomarkers for various diseases. It offers Olink Discovery, a solution that allows users to target and validate thousands of proteins in one simple workflow; and Olink Proteomics, a platform which is aimed at understanding how proteins affect gene expression, cell signaling, and protein-protein interactions. Olink went public March 2021 and is headquartered in Uppsala, Sweden.